# A Clinical Study of Mesenchymal Stem Cell Exosomes Nebulizer for the Treatment of ARDS

> **NCT04602104** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ruijin Hospital** · enrollment: 18 (actual)

## Conditions studied

- Acute Respiratory Distress Syndrome

## Interventions

- **BIOLOGICAL:** low dose hMSC-Exos
- **BIOLOGICAL:** medium dose hMSC-Exos
- **BIOLOGICAL:** high dose hMSC-Exos
- **BIOLOGICAL:** Dosage 1of hMSC-Exos
- **BIOLOGICAL:** Dosage 2 of hMSC-Exos
- **BIOLOGICAL:** No hMSC-derived exosomes

## Key facts

- **NCT ID:** NCT04602104
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-30
- **Primary completion:** 2022-11-10
- **Final completion:** 2023-01-11
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04602104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04602104, "A Clinical Study of Mesenchymal Stem Cell Exosomes Nebulizer for the Treatment of ARDS". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04602104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*